Overview
Maitane Catalan-Andion practices practicing medicine in Nino Jesus, Spain.
Their clinical expertise encompasses Rhabdomyosarcoma, Papilledema, and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maitane Catalan-Andion
Is Maitane Catalan-Andion a top-rated expert for Rhabdomyosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Maitane Catalan-Andion is classified as an Experienced expert for Rhabdomyosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maitane Catalan-Andion participate in research or clinical trials?
Yes. Maitane Catalan-Andion has published 11 articles and abstracts on conditions like Rhabdomyosarcoma. You can view a list of Maitane Catalan-Andion's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Neurotoxicity SyndromesCatalan-Andion isExperienced. Learn about Neurotoxicity Syndromes.
- PapilledemaCatalan-Andion isExperienced. Learn about Papilledema.
- RhabdomyosarcomaCatalan-Andion isExperienced. Learn about Rhabdomyosarcoma.